ACAshley Collazo

Ashley Collazo

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ashley Collazo has a total of 37 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Pseudoleadership and the staying power of minoritized faculty

    by Cleavon Covington, Elisha Jackson, Zuleica Santiago Delgado, Deyanna Boston, Nicole M. Jackson, Joy Howell, Ashley Collazo, Kendall M. Campbell

  • Open Access

    Patient and healthcare professionals’ perceptions of educational tools to reduce urine culture contamination in outpatient clinics: a qualitative study

    by Ashley Collazo, Trenton M. Haltom, Johanan Luna Rodriguez, Kiara Olmeda, Azalia Mancera, Fabrizia Faustinella, Michael K. Paasche-Orlow, Zach Landis-Lewis, Roger Zoorob, Barbara W. Trautner, et al.

    Objective: Iteratively develop educational tools (instructional video and flyer) to improve midstream clean catch (MSCC) urine sample collection using patient and healthcare professionals’ input. Design: Multi-method qualitative study. Setting: Outpatient clinics in Houston, Texas, United States. Participants: Adult patients recruited from public and private clinics ( n = 12). Healthcare professionals (HCP; nurses and medical assistants) ( n = 12) providing care at participating clinics. Methods: Twelve patient interviews and three focus groups with HCPs (May 2024–November 2024). Interviews discussed patient experiences using the educational tools to guide urine specimen collection. Focus groups elicited HCPs’ perspectives on the comprehensibility and utility of the tools in their respective clinics. We identified themes using directed content analysis. Results: We garnered insight into knowledge gaps and barriers for completing the MSCC process. MSCC instructions in existing educational tools were poorly understood by patients, especially among those with limited understanding of urogenital anatomy. Patient barriers to MSCC collection included physical difficulties due to poor urine stream control, mobility issues, and obesity. Patients and HCPs reported that our tools addressed patient gaps in understanding of MSCC instructions. Patients and HCPs also suggested that we accompany our tools with assistive devices and dedicated surfaces in the clinic bathrooms, to better meet patients’ needs in urine specimen collection. Conclusions: Initial feedback was promising that our educational tools would improve the MSCC collection process for patients. In next steps, we will conduct feasibility pilot testing followed by a randomized controlled trial to test the effectiveness of reducing urine culture contamination.

  • Open Access

    ‘In Texas, everybody wants antibiotics’: reducing inappropriate antibiotic expectations and use with a provider–patient communication tool in primary care

    by Ashley Collazo, Paige Wermuth, Johanan Luna Rodriguez, Kiara Olmeda, Azalia Mancera, Fabrizia Faustinella, Michael K Paasche-Orlow, Roger Zoorob, Barbara Wells Trautner, Larissa Grigoryan

    Background/objective: Patients often expect antibiotics for self-limiting diseases, pressuring providers to prescribe antibiotics unnecessarily. These expectations also contribute to the unsafe practice of taking antibiotics without a prescription (non-prescription use), such as pills retained from prior prescriptions or antibiotics from non-medical sources. Previous work shows that non-prescription use is due to strong, widely held misconceptions regarding the curative power of antibiotics. To reduce unnecessary use of antibiotics, we developed and pilot-tested a patient-focused, bilingual (English and Spanish) educational tool with patient and provider stakeholder input. The tool, a trifold brochure, included information on safe antibiotic use, potential antibiotic harms and symptom management with over-the-counter medications. Design: Using a qualitative design, we conducted a two-phase study to (1) develop a provider–patient communication tool and (2) pilot-test the tool in primary care clinics. Development of the tool involved patient advisory board meetings and healthcare professional (HCP) focus groups. Pilot-testing of the tool was done through semistructured interviews of randomly recruited patients from primary clinic waiting rooms and their providers. Setting: Publicly funded safety net primary care clinics in Texas. Participants: Patients (n=18) and HCPs (nurses, medical assistants, pharmacists, nurse practitioners and physicians) (n=14) from participating clinics. Result: Themes were extracted from the qualitative data. Main themes from the development phase highlighted the need to create a simple tool to make it clear that antibiotics are not used to treat viral infections, pain or allergies and that using antibiotics without consulting a medical professional is not safe. During pilot-testing, providers noted the tool helped adjust patients’ antibiotic expectations. Providers felt that the tool gave them credibility in scenarios where antibiotics were not indicated. Patients felt that the tool provided alternatives to antibiotics for symptom relief. Patients and providers found the tool useful in supporting patient–provider communication around antibiotic use. Conclusions: A stakeholder-driven, patient-focused educational tool addressing inappropriate antibiotic use facilitated patient–provider communication around antibiotic usage and helped manage patients’ antibiotic expectations. Embedding this tool into a community-facing intervention may reduce use of antibiotics without a prescription.


  • Physiologic Differences in Vital Signs and Urine Tests in Spinal Cord Injury and the Effects on Urinary Tract Infection Diagnosis

    by Ashley Collazo, Larissa Grigoryan, Cheng Jiang, Roger Zoorob, Barbara W. Trautner, Felicia Skelton

    Objective: The aim of the study was to establish the physiologic baseline (person’s physiologic state when their health is stable) for vital signs and urine lab measurements after spinal cord injury. Design: This case-control study using outpatient data from the national Veteran’s Health Administration Corporate Data Warehouse included 2000 veterans with spinal cord injury (cases) and 2000 Veterans without spinal cord injury (controls) between 2018–2019. Cases and controls were randomly selected, and frequency matched for age, sex, race, ethnicity, and Deyo Comorbidity Index. Results: Spinal cord injury patients had lower temperature, heart rate, respiratory rate, and systolic and diastolic blood pressures than non–spinal cord injury ( P < 0.05). Pyuria and hematuria were higher in spinal cord injury patients, with approximately 73% of tetraplegic and paraplegic patients having urine white blood cells above 10 high power field. Tetraplegic patients had lower heart rate, systolic blood pressure, and diastolic blood pressure than both paraplegic patients and non–spinal cord injury patients ( P < 0.001). Conclusions: Baseline vital signs were lower in spinal cord injury patients compared with non–spinal cord injury patients. Lower systolic blood pressure, diastolic blood pressure, and heart rate were associated with higher levels of spinal cord injury. Tetraplegic and paraplegic patients had baseline pyuria above 10 high power field suggesting the criteria for pyuria as a positive indicator of urinary tract infection should be different in patients with spinal cord injury than those without spinal cord injury.

  • Open Access

    Development of a Risk Score to Aid With the Diagnosis of Infections After Spinal Cord Injury: Protocol for a Retrospective Cohort Study

    by Felicia Skelton, Larissa Grigoryan, Joann Pan, Ashley Collazo, Barbara Trautner

    Background: Patients with spinal cord injury (SCI) who develop urinary tract infection (UTI) present differently than the non-SCI population. UTIs can cause loss of quality of life and even lead to life-threatening complications including urosepsis. Challenges in SCI management include distinguishing symptomatic UTI from asymptomatic bacteriuria (ASB), which occurs often in patients with SCI, and the lack of standardization in UTI diagnosis in SCI. Objective: This study aims to set the foundation for the development of a risk score to improve diagnostic accuracy of UTI after SCI. Methods: This study will use data from the Veterans Health Administration Corporate Data Warehouse from national outpatient clinics. It will use 2 approaches: (1) a case-control study comparing frequency-matched healthy SCI cases (n=2000) with healthy non-SCI controls (n=2000) to establish a physiologic baseline for vital sign and lab measurements after SCI and (2) a retrospective cohort study of patients with SCI (n=400) to determine the positive predictive value of the baseline vital signs and lab measurements found in step 1, from which a threshold for clinically meaningful UTI after SCI will be established. Results: The study was funded in May 2023, and initial data extraction started in early 2024 and is expected to be completed in 2026. Data extraction, analysis, and results for aim 1 were completed as of manuscript submission. For aim 1, we hypothesize that SCI will be associated with lower temperature, heart rate, and systolic blood pressure when compared with non-SCI controls. SCI will also be associated with higher baseline levels of pyuria and peripheral white blood cells when compared with non-SCI controls. Data extraction for aim 2 will begin in year 1, and analysis and results will be completed in year 2. For aim 2, we hypothesize that pyuria, heart rate, and temperature measurements will have a high positive predictive value for clinically meaningful UTI. Conclusions: Once complete, this study will be the basis for our future work developing a risk score to aid with the diagnosis of UTI after SCI and prevent antibiotic overuse in patients with SCI. International Registered Report Identifier (IRRID): DERR1-10.2196/52610

  • Institutional characteristics, faculty rank and URM faculty representation

    by Kendall M. Campbell, Ashley Collazo, Xiaoying Yu, Christen Walcher

  • Open Access

    A Practical Guide to Identifying a Supportive Work Environment for Underrepresented Faculty in Academic Medicine

    by Ashley Collazo, Christen Walcher, Kendall M. Campbell

    Much has been added to the literature to better characterize and define the experiences of faculty who are underrepresented in medicine and other health professions. Additions include approaches for faculty development and suggestions for institutions on how to create equitable environments that promote the success and advancement of this group. Despite all these additions to the literature, health professions educators still lack practical approaches to determine supportive academic health center environments that are receptive to their needs and resourced to promote their career success. To the authors’ knowledge, there has not been a paper that uses a validated framework and practical approach to advise underrepresented faculty in the health professions on how to evaluate an academic health system. Adapting criteria used to determine the rigor of qualitative research, the authors propose such an evaluative approach.

  • Trends Among Women in Academic Medicine Faculty Ranks

    by Ashley Collazo, Xiaoying Yu, Quratulanne Jan, Cathy Z. Xie, Kendall M. Campbell

    Introduction: Similar proportions of women and men have entered medical school since 2003. However, career advancement and promotion for women continues to be fraught with disparities and inequalities. Building on current literature, this study explores the rates of change of female faculty in faculty ranks over the last 10 years to gain a more comprehensive view of the faculty trends of women in academic medicine. Methods: Using the Faculty Administrative Management Online User System database, counts by gender and faculty rank at each Association of American Medical Colleges (AAMC) academic medical school were obtained. Statistical analysis was done using generalized estimating equations modeling to assess rates of change for each gender from 2012 to 2021. Results: Higher proportions of female faculty are concentrated at the Instructor and Assistant Professor level and lower proportions at the Associate Professor and Professor rank compared to male faculty. Over the study period, female faculty showed increased rate change compared to male faculty of 1.007 (95% confidence interval [CI]: 1.002–1.012) for Associate Professor rank and 1.012 (95% CI: 1.007–1.016) for Professor rank. At the Instructor and Assistant Professor levels, female faculty decreased at a relative rate of 0.980 (95% CI: 0.969–0.990) and 0.995 (95% CI: 0.992–0.997) each year, respectively. Conclusion: Female faculty continue to be concentrated at the junior faculty rank. Rate changes at the senior faculty rank for female faculty have slightly improved over the last 10 years compared to male faculty. However, this improvement is minimal, and work is still needed to achieve true gender equity in academic medicine.


  • Are We Really Retaining URiM Faculty in Academic Medicine?

    by Ashley Collazo, Karen E. Schlag, Ernst Nicanord, Kendall M. Campbell

    Introduction Previous studies have identified the need to improve recruitment and retention of faculty who are underrepresented in medicine (URiM); however, it is unclear to what extent medical schools have been able to sustain growth and retain URiM faculty representation. Methods Numbers of URiM faculty at each AAMC medical school from 2012 to 2021 were obtained from the Association of American Medical Colleges Faculty Administrative Management Online User System database. Year-over-year percent change was calculated for each school and year of the study period for all URiM faculty, junior URiM faculty, and senior URiM faculty. Pearson's correlation was used to compare percent change in 1 year to the previous and subsequent years for all three groups. Pearson's correlation coefficients were also used to compare percent change between junior and senior URiM faculty for the same, previous, and subsequent years. Results The percentage change for URiM faculty at all ranks between adjacent years occurring from 2012 to 2021 was weakly and negatively associated (r = − 0.06, p value = 0.03). There was significant positive correlation between the percent change in junior URiM faculty and senior URiM faculty in the same year (r = 0.11) and previous year (r = 0.09). Discussion URiM faculty growth in 1 year is not sustained in the next year. More research is needed to better understand efforts at retention of URiM faculty in academic medicine.


  • Open Access

    Development of a Risk Score to Aid With the Diagnosis of Infections After Spinal Cord Injury: Protocol for a Retrospective Cohort Study (Preprint)

    by Felicia Skelton, Larissa Grigoryan, Joann Pan, Ashley Collazo, Barbara Trautner

    BACKGROUND Patients with spinal cord injury (SCI) who develop urinary tract infection (UTI) present differently than the non-SCI population. UTIs can cause loss of quality of life and even lead to life-threatening complications including urosepsis. Challenges in SCI management include distinguishing symptomatic UTI from asymptomatic bacteriuria (ASB), which occurs often in patients with SCI, and the lack of standardization in UTI diagnosis in SCI. OBJECTIVE This study aims to set the foundation for the development of a risk score to improve diagnostic accuracy of UTI after SCI. METHODS This study will use data from the Veterans Health Administration Corporate Data Warehouse from national outpatient clinics. It will use 2 approaches: (1) a case-control study comparing frequency-matched healthy SCI cases (n=2000) with healthy non-SCI controls (n=2000) to establish a physiologic baseline for vital sign and lab measurements after SCI and (2) a retrospective cohort study of patients with SCI (n=400) to determine the positive predictive value of the baseline vital signs and lab measurements found in step 1, from which a threshold for clinically meaningful UTI after SCI will be established. RESULTS The study was funded in May 2023, and initial data extraction started in early 2024 and is expected to be completed in 2026. Data extraction, analysis, and results for aim 1 were completed as of manuscript submission. For aim 1, we hypothesize that SCI will be associated with lower temperature, heart rate, and systolic blood pressure when compared with non-SCI controls. SCI will also be associated with higher baseline levels of pyuria and peripheral white blood cells when compared with non-SCI controls. Data extraction for aim 2 will begin in year 1, and analysis and results will be completed in year 2. For aim 2, we hypothesize that pyuria, heart rate, and temperature measurements will have a high positive predictive value for clinically meaningful UTI. CONCLUSIONS Once complete, this study will be the basis for our future work developing a risk score to aid with the diagnosis of UTI after SCI and prevent antibiotic overuse in patients with SCI. CLINICALTRIAL INTERNATIONAL REGISTERED REPORT DERR1-10.2196/52610